logo

For the Inventor, By the Inventor

Bryn Mawr, PA, United States of America

Giovanni Rovera

USPTO Granted Patents = 8

Average Co-Inventor Count = 2.8

ph-index = 4

Forward Citations = 72(Granted Patents)


Company Filing History:

goldMedal8 out of 243 
 
The Wistar Institute
 patents

Years Active: 1993-2004

Loading Chart...
8 patents (USPTO):Explore Patents
1. 6828147 - Method of modifying cytotoxic cells and uses thereof (2004-12-07),
2. 6716425 - Method of preventing cancer recurrence (2004-04-06),
3. 6221635 - Methods for solid-phase amplification of DNA template (SPADT) using multiarrays (2001-04-24),
4. 6022538 - Method of treating malignancies (2000-02-08),
5. 5820856 - Modified TALL-104 cells to treat cancer (1998-10-13),
6. 5702702 - Modified cytotoxic tall cell line and compositions and methods for (1997-12-30),
7. 5683690 - Modified cytotoxic tall cell line and compositions and methods for (1997-11-04),
8. 5272082 - Cytotoxic T-ALL cell lines and uses therefor (1993-12-21),

Title: Giovanni Rovera: Innovator in Cancer Treatment

Introduction

Giovanni Rovera is a prominent inventor based in Bryn Mawr, PA, known for his significant contributions to cancer research and treatment. With a total of eight patents to his name, he has made remarkable strides in the field of immunotherapy.

Latest Patents

Among his latest patents is a method of modifying cytotoxic cells and their uses, specifically focusing on TALL-104 cells. This innovation allows for the enhancement of cytotoxicity and growth properties of these cells, as well as the expression of preferred phenotypes. The method involves culturing the cells in an effective amount of IL-15, followed by gamma irradiation to halt proliferation. Another notable patent is a method for preventing cancer recurrence. This method describes a course of therapy using modified TALL-104 cells for treating cancer in patients with a functional immune system, without the need for immunosuppressive agents.

Career Highlights

Giovanni Rovera has worked with esteemed institutions such as the Wistar Institute of Anatomy & Biology and the Wistar Institute. His work has been pivotal in advancing cancer treatment methodologies and improving patient outcomes.

Collaborations

He has collaborated with notable colleagues, including Daniela Santoli and Alessandra Cesano, contributing to a rich environment of innovation and research.

Conclusion

Giovanni Rovera's work exemplifies the intersection of innovation and healthcare, particularly in the realm of cancer treatment. His patents and collaborations continue to influence the field significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…